Ramsay Santé Reports Revenue Growth Amidst Pricing Challenges

Ramsay Health Care ( (AU:RHC) ) has provided an announcement.

Ramsay Santé reported a 5.1% increase in revenue for the nine months ending March 2025, driven by activity growth and acquisitions, despite facing pricing challenges. The company’s EBITDA remained stable, with cost-saving measures helping to offset reduced government funding and inflationary pressures. The expansion of day hospitals and digitalization efforts, including AI in medical reporting and remote monitoring, are enhancing patient care and positioning the company for future growth.

The most recent analyst rating on (AU:RHC) stock is a Hold with a A$43.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.

More about Ramsay Health Care

Ramsay Health Care is a prominent player in the healthcare industry, focusing on providing comprehensive medical services. Its subsidiary, Ramsay Santé, operates in the European market and is listed on Euronext. The company is involved in offering healthcare services through hospitals and primary care centers, with a significant presence in France and Sweden.

Average Trading Volume: 1,241,966

Technical Sentiment Signal: Sell

Current Market Cap: A$8.36B

Find detailed analytics on RHC stock on TipRanks’ Stock Analysis page.